Efficacy and Safety of HS-20094 in Patients with Type 2 Diabetes-A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

被引：0
|
作者：
Liu, Lin
Shi, Xiaoxia
He, Fei
Cheng, Zhifeng
Song, Weihong
Wang, Zhongjing
Cui, Yimin
Zhang, Junqing
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-733-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
733-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of HS-20094 in patients with type 2 diabetes: a randomised double-blind, placebo-controlled, phase 2 trail
    Liu, L.
    Shi, X.
    Cheng, Z.
    Song, W.
    Wang, Z.
    He, F.
    Cui, Y.
    Zhang, J.
    DIABETOLOGIA, 2024, 67 : S351 - S351
  • [2] Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
    Zhang, Bo
    Cheng, Zhifeng
    Chen, Ji
    Zhang, Xin
    Liu, Dexue
    Jiang, Hongwei
    Ma, Guoqing
    Wang, Xiaoyun
    Gan, Shenglian
    Sun, Juan
    Jin, Ping
    Yi, Jianjun
    Shi, Bimin
    Ma, Jianhua
    Ye, Shandong
    Wang, Guixia
    Ji, Linong
    Gu, Xuejiang
    Yu, Ting
    An, Pei
    Deng, Huan
    Li, Haoyu
    Li, Li
    Ma, Qingyang
    Qian, Lei
    Yang, Wenying
    DIABETES CARE, 2024, 47 (01) : 160 - 168
  • [3] Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial
    Ji, Linong
    Lu, Jinmiao
    Gao, Leili
    Ying, Changjiang
    Sun, Jiao
    Han, Jie
    Zhao, Wenhua
    Gao, Yunming
    Wang, Kun
    Zheng, Xin
    Xie, Daosheng
    Ding, Juping
    Zhao, Jiahong
    Yu, Qiang
    Wang, Tong
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3671 - 3681
  • [4] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, H. K.
    Lee, S. H.
    Min, K. W.
    Park, S. W.
    Chung, C. H.
    Park, K. S.
    Choi, S. H.
    Song, K. -H.
    Kim, D. -M.
    Lee, M. -K.
    Sung, Y. A.
    Baik, S. H.
    Kim, I. J.
    Cha, B. -S.
    Park, J. H.
    Ahn, Y. B.
    Lee, I. -K.
    Yoo, S. -J.
    Kim, J. T.
    Park, I. B.
    Park, T. S.
    Yoon, K. -H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
  • [5] Efficacy and safety of linagliptin plus insulin in Chinese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
    Yang, Wenying
    Shen, Jie
    Ye, Binqi
    Qi, Sheng
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [6] Creatine in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Gualano, Bruno
    Painneli, Vitor De Salles
    Roschel, Hamilton
    Artioli, Guilherme Giannini
    Neves, Manoel, Jr.
    De Sa Pinto, Ana Lucia
    Rossi Da Silva, Maria Elizabeth
    Cunha, Maria Rosaria
    Garcia Otaduy, Maria Concepcion
    Leite, Claudia Da Costa
    Ferreira, Julio Cesar
    Pereira, Rosa Maria
    Brum, Patricia Chakur
    Bonfa, Eloisa
    Lancha, Antonio Herbert, Jr.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (05): : 770 - 778
  • [7] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis
    Leber, Andrew
    Hontecillas, Raquel
    Juni, Nuria Tubau
    Bassaganya-Riera, Josep
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S821 - S821
  • [8] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
  • [9] Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trial
    Gao, Leili
    Bian, Fang
    Pan, Tianrong
    Jiang, Hongwei
    Feng, Bo
    Jiang, Chengxia
    Sun, Jia
    Xiao, Jianzhong
    Yan, Pangke
    Ji, Linong
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 280 - 290
  • [10] Efficacy and safety of empagliflozin as add-on to insulin in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial
    Sone, Hirohito
    Kaneko, Tatsuroh
    Shiki, Kosuke
    Tachibana, Yoshifumi
    Pfarr, Egon
    Lee, Jisoo
    Tajima, Naoko
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 417 - 426
12345